Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

BACKGROUND: Endothelial dysfunction, largely dependent on impaired nitric oxide bioavailability, has been reportedly associated with incident type 2 diabetes. Our aim was to test the hypothesis that asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide formation, might be linke...

Descripción completa

Detalles Bibliográficos
Autores principales: Surdacki, Andrzej, Kruszelnicka, Olga, Rakowski, Tomasz, Jaźwińska-Kozuba, Aleksandra, Dubiel, Jacek S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642017/
https://www.ncbi.nlm.nih.gov/pubmed/23578341
http://dx.doi.org/10.1186/1475-2840-12-64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642017/
https://www.ncbi.nlm.nih.gov/pubmed/23578341
http://dx.doi.org/10.1186/1475-2840-12-64

Ejemplares similares